GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...
US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T the...
The Bhutan-International Vaccine Institute (IVI) Collaborating Centre has been officially launched in Thimphu, Bhutan, m...
The BIO Asia–Taiwan 2025 Exhibition opened its doors today at the Taipei Nangang Exhibition Center, TaiNEX 1. With...
Day 2 of BIO Asia–Taiwan 2025 unfolded with palpable energy and a heightened sense of purpose as stakeholders from...
Coverage by Hithaishi Bhaskar The BIO Asia–Taiwan 2025 convention officially kicked off on 23rd july at Taipei Na...
South Korea has emerged as a major player in the global biopharmaceutical landscape, transforming from a generic drug ma...
Life Biosciences, a US-based biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent mul...
Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vacc...
Alloy Therapeutics Co. has announced the signing of a Memorandum of Understanding (MoU) with the Kansai Startup Academia...
BIO Asia–Taiwan 2025, the region’s premier and most expansive biotechnology event, officially opens its door...
The Global Antibiotic Research & Development Partnership (GARDP) and Institute of Science Tokyo, in Japan, have sign...
To help bridge a critical funding gap for early-stage tech ventures in Asia, National University of Singapore (NUS) is l...
Australia-based contract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and...
US-headquartered NKGen Biotech, Inc. a clinical-stage biotechnology company focused on the development and commerci...
10x Genomics, Inc., a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GI...
China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...
CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...
Japan-headquartered Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately&nb...
Over the last 50 years, Switzerland has emerged as one of the most innovative and collaborative biotech hubs in the worl...
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of India-based Biocon Ltd. has ...
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers ...
A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs int...
